Wenzel et al. examined the characteristics of 6690 patients with high-risk prostate cancer from the NCCN database and they developed a model that predicted downgrading using the parameters of biopsy Gleason patterns, PSA, cT stage, and the number of positive biopsy cores. The gene discussed is KLK3; the disease is Familial prostate cancer.